Skip to Content

Moderna vaccine. Photo credit: Ian Hutchinson

Four vaccine company stocks expected to rise

A year ago, in the summer of 2020, the Covid-19 vaccine was still an aspiration of pharmaceutical companies. However, just twelve months later, in countries such as Canada, the United Kingdom or Spain, more than 50 percent of its inhabitants have had both jabs.

Published: July 28, 2021, 7:34 am

    Read more

    Behind the vaccines are four main manufacturers: AstraZeneca, Johnson & Johnson, Pfizer and Moderna. These latter two are the most demanded by the countries of the European Union, which has slowed down the purchases of the other two to prioritize the vaccines of the two American companies, which were the first to announce the creation of the vaccine last November.

    Moderna is the company that has benefited the most on the stock market, rising 297 percent in twelve months. Thus, the company has gone from trading at 74 dollars (62,78 euros) to 320 dollars (271 euros). This means that whoever invested 1000 euros in July 2020 will now have 4316 euros thanks to its meteoric rise.

    Shares of Moderna jumped 7,8 percent to a record high on Friday after European health officials recommended authorizing the vaccine for children from the age of 12 and older. The European Medicines Agency’s Committee for Medicinal Products for Human Use adopted a positive outlook on Moderna’s vaccine, despite warnings from medical professionals. The European Commission will now consider granting authorization for use in adolescents.

    “As we help to combat the pandemic, we hope to be able to help get adolescents safely back to school this fall,” Moderna CEO Stéphane Bancel said in a press release. The US government is co-patent holder of Moderna through the National Institutes of Health, which is a clear conflict of interest.

    Calls for booster shots against “variants” are also growing louder and these potential new authorizations for Moderna’s product could provide a significant boost to the company’s revenue and profits in the coming quarters.

    Far behind is Pfizer, with an increase of 17,9 percent in the last twelve months. The company, which has a market valuation higher than Moderna by 100 000 million dollars (85 000 million euros), has gone from trading at 35,8 dollars (30,37 euros) to 41,36 dollars (35,09). In this case, whoever invested 1000 euros will now have 1155 euros.

    But Pfizer, allied to the BioNTech laboratory, announced a 92 percent increase in its quarterly turnover compared to the previous year, reaching almost $19 billion. Its quarterly net profit increased by 59 percent.

    For its part, Johnson & Johnson, the largest of the four companies with a valuation four times higher than Moderna and twice higher than Pfizer, has risen to 13,2 percent in the last twelve months.

    AstraZeneca is the only company of the four that has lost on the stock market in the last year. The British concern has been surpassed by Moderna in terms of valuation. But 21 analysts offering 12-month price forecasts for AstraZeneca PLC have estimated a 15,35 percent increase.

    Consider donating to support our work

    Help us to produce more articles like this. FreeWestMedia is depending on donations from our readers to keep going. With your help, we expose the mainstream fake news agenda.

    Keep ​your language polite​. Readers from many different countries visit and contribute to Free West Media and we must therefore obey the rules in​,​ for example​, ​Germany. Illegal content will be deleted.

    If you have been approved to post comments without preview from FWM, you are responsible for violation​s​ of​ any​ law. This means that FWM may be forced to cooperate with authorities in a possible crime investigation.

    If your comments are subject to preview ​by FWM, please be patient. We continually review comments but depending on the time of day it can take up to several hours before your comment is reviewed.

    We reserve the right to del​ete​ comments that are offensive, contain slander or foul language, or are irrelevant to the discussion.


    Buying farmland: Bill Gates is ‘not welcome’ in North Dakota

    BismarckThe billionaire is considered the largest owner of farmland in the United States. This puts him in a "unique position to harm conventional agriculture," according to a Spanish newspaper. Resistance is therefore growing in North Dakota.

    Former US NATO policy planner urges Ukraine to cut a deal

    WashingtonThere has been a recent rise in voices in the US advising a negotiated settlement to the Ukraine war – positioning themselves against the Kiev government, which is clinging to continued fighting despite mounting casualties.

    Genetics: Scientists wanted friendly hamsters but made them much more aggressive

    AtlantaGeneticists admitted that they had been "really surprised" after a gene-editing experiment with the CRISPR/Cas9 technique went horribly wrong. They had instead turned the hamsters they had been injecting with their potion into hyper-aggressive monsters.

    Runner dies after Brooklyn marathon, 15 others hospitalized

    New YorkA runner died on Saturday morning after completing the Brooklyn Half Marathon, authorities said. The 30-year-old man possibly went into cardiac arrest around 9 am local time and was taken to hospital, where he was pronounced dead.

    US faces biggest energy crisis in half a century

    WashingtonThe energy crisis the US is facing now may be the worst in 50 years. This was voiced by none other than the head of the US Oil and Gas Association, Tim Stewart.

    Documentary on the rigging of 2020 US election

    WashingtonAmerican political commentator Dinesh D’Souza has produced a documentary about how the 2020 US presidential election was rigged in favor of Joe Biden. Since 2 May 2022, his film has been screened in 250 theaters.

    Americans are beginning to doubt Biden’s mental capacity

    WashingtonIt turns out that the world has been making fun of President Biden for a reason. Judging by opinion polls, many American citizens believe that it is time for their geriatric leader to resign.

    New US ‘Disinformation Governance Board’ director linked to Ukraine

    WashingtonThe new managing director of a US watchdog set up to fight Russian "disinformation" advised the Ukrainian government. The US Department of Homeland Security has appointed Nina Jankowicz, previously also a propagandist for the Democratic Party.

    US food production threatened by mysterious fires in meat plants

    More and more food processing plants are going up in flames in the US. Sixteen such incidents have been recorded so far. The background is unclear, but terrorism is being ruled out.

    Being ‘non-binary’ in the US has become a gainful choice

    Palm Springs, CaliforniaIn the US, the privileging of sexual minorities compared to the "normal" rest of the population is making great strides. Being "non-binary" is a now also a lucrative choice: An amount of $1000 will be paid every month to each individual who identify as a transgender American.

    Go to archive